Moscow. June 2. INTERFAX.RU — the Russian defense Ministry announced that the country begin clinical trials of this vaccine against coronavirus. Testing will take place on volunteers from the military, they are already selected.
“To test the safety and efficacy of the vaccine selected 50 servicemen, including five women, voluntarily willing to participate in testing modern medication,” — said in a statement received by “Interfax”.
participated In the development of the military — employees of the 48th Central research Institute of the Ministry of defense. The tests on the basis of this Institute. On 3 June the first group of volunteers will arrive in a special medical facility at the Institute for advanced in-depth medical examination and preparation for the experiment.
on may 22, it became known that the National research centre of epidemiology and Microbiology named after N. F. Gamalei of the Ministry of health (NICEM) staff informally has experienced vectored vaccine COVID-19. The centre’s Director, academician Alexander Ginzburg said that the experiment was successful. According to him, negative side effects from vaccination was observed from the grafted developed immunity.
also clarified that we are talking about a promising vector vaccine of NIZAM based on DNA, adenovirus, in which the integrated gene of the coronavirus SARS-CoV-2. Adenovirus is used as a “container” to deliver coronavirus gene in a cell, start there protein synthesis shell of a new coronavirus (the same “crown”, through which the coronavirus got their name) and “introduce” in this way the immune system with a potential enemy. Vaccines of this type are called vector.
the fact that the military involved in the development of vaccines, April 7, said the head of the troops of radiation, chemical and biological protection (NBC) Lieutenant General Igor Kirillov.
Experts of the 48th Central research Institute of the troops of radiation, chemical and biological protection (NBC) of the Ministry of defense conducted this work together with Nizama. Earlier in the 48th Central research Institute tested the vaccine against Ebola, middle East respiratory syndrome MERS and a universal flu vaccine.
it was Reported that on a vaccine from COVID-19 there are seven Russian scientific grounds. Currently six vaccines against coronavirus tested at the Novosibirsk state research center “Vector” of Rospotrebnadzor, two vaccines develops the company “Biogard” and another prepares St. Petersburg scientific research Institute of vaccines and sera. In addition, the development of a vaccine doing the FMBA and the Russian Academy of Sciences.
